Clinical efficacy of tumor organoid‐guided cancer therapy for locally advanced unresectable or metastatic breast cancer

Documenti analoghi

• Establishment of patient‐derived organoids for guiding personalized therapies in breast cancer patients
  di: Huizi Wu, et al.
  Pubblicazione: (2024)
• Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma
  di: Chenliang Zhou, et al.
  Pubblicazione: (2024)
• New FDA approval for immunotherapy‐based combination treatment for unresectable or metastatic liver cancer
  di: Mary Beth Nierengarten
  Pubblicazione: (2025)
• Longer progression‐free survival with targeted therapy for patients with metastatic breast cancer
  di: Mary Beth Nierengarten
  Pubblicazione: (2025)
• Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
  di: Salih Tunbekici, et al.
  Pubblicazione: (2025)